JP2005520536A5 - - Google Patents

Download PDF

Info

Publication number
JP2005520536A5
JP2005520536A5 JP2003577810A JP2003577810A JP2005520536A5 JP 2005520536 A5 JP2005520536 A5 JP 2005520536A5 JP 2003577810 A JP2003577810 A JP 2003577810A JP 2003577810 A JP2003577810 A JP 2003577810A JP 2005520536 A5 JP2005520536 A5 JP 2005520536A5
Authority
JP
Japan
Prior art keywords
nucleic acid
cap
group
sequence selected
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003577810A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005520536A (ja
Filing date
Publication date
Priority claimed from US10/105,612 external-priority patent/US20030165878A1/en
Application filed filed Critical
Publication of JP2005520536A publication Critical patent/JP2005520536A/ja
Publication of JP2005520536A5 publication Critical patent/JP2005520536A5/ja
Pending legal-status Critical Current

Links

JP2003577810A 2002-03-20 2003-03-17 Ｍｃｍ３ａｐの変更された発現に関連する癌における新規組成物および方法 Pending JP2005520536A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/105,612 US20030165878A1 (en) 2000-12-22 2002-03-20 Novel compositions and methods in cancer associated with altered expression of MCM3AP
PCT/US2003/008071 WO2003079977A2 (en) 2002-03-20 2003-03-17 Novel compositions and methods in cancer associated with altered expression of mcm3ap

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009107191A Division JP2009195244A (ja) 2002-03-20 2009-04-24 Ｍｃｍ３ａｐの変更された発現に関連する癌における新規組成物および方法

Publications (2)

Publication Number Publication Date
JP2005520536A JP2005520536A (ja) 2005-07-14
JP2005520536A5 true JP2005520536A5 (enExample) 2006-05-11

Family

ID=28452442

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003577810A Pending JP2005520536A (ja) 2002-03-20 2003-03-17 Ｍｃｍ３ａｐの変更された発現に関連する癌における新規組成物および方法
JP2009107191A Pending JP2009195244A (ja) 2002-03-20 2009-04-24 Ｍｃｍ３ａｐの変更された発現に関連する癌における新規組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009107191A Pending JP2009195244A (ja) 2002-03-20 2009-04-24 Ｍｃｍ３ａｐの変更された発現に関連する癌における新規組成物および方法

Country Status (6)

Country Link
US (2) US20030165878A1 (enExample)
EP (1) EP1490690A4 (enExample)
JP (2) JP2005520536A (enExample)
AU (1) AU2003225826B2 (enExample)
CA (1) CA2479719A1 (enExample)
WO (1) WO2003079977A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070207120A1 (en) * 2004-04-14 2007-09-06 Sarah Drayton Selective Killing Of Cancer Cells By Induction Of Acetyltransferase Via Tnf-Alpha And Il-6
JP5435529B2 (ja) 2005-09-02 2014-03-05 東レ株式会社 腎ガン診断、腎ガン患者予後予測のための組成物および方法

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS6023084B2 (ja) * 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4469863A (en) * 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
US4640835A (en) * 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4496689A (en) * 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US5430136A (en) * 1984-10-16 1995-07-04 Chiron Corporation Oligonucleotides having selectably cleavable and/or abasic sites
US5235033A (en) * 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
US5034506A (en) * 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
EP0206448B1 (en) * 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hemoglobin combined with a poly(alkylene oxide)
US4791192A (en) * 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US5359100A (en) * 1987-10-15 1994-10-25 Chiron Corporation Bifunctional blocked phosphoramidites useful in making nucleic acid mutimers
US5124246A (en) * 1987-10-15 1992-06-23 Chiron Corporation Nucleic acid multimers and amplified nucleic acid hybridization assays using same
US5700637A (en) * 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US5216141A (en) * 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
GB8823869D0 (en) * 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5386023A (en) * 1990-07-27 1995-01-31 Isis Pharmaceuticals Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling
US5602240A (en) * 1990-07-27 1997-02-11 Ciba Geigy Ag. Backbone modified oligonucleotide analogs
US5545806A (en) * 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5625126A (en) * 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5661016A (en) * 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5633425A (en) * 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
KR100272077B1 (ko) * 1990-08-29 2000-11-15 젠팜인터내셔날,인코포레이티드 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물
US5644048A (en) * 1992-01-10 1997-07-01 Isis Pharmaceuticals, Inc. Process for preparing phosphorothioate oligonucleotides
US5681697A (en) * 1993-12-08 1997-10-28 Chiron Corporation Solution phase nucleic acid sandwich assays having reduced background noise and kits therefor
US5637684A (en) * 1994-02-23 1997-06-10 Isis Pharmaceuticals, Inc. Phosphoramidate and phosphorothioamidate oligomeric compounds
US5580731A (en) * 1994-08-25 1996-12-03 Chiron Corporation N-4 modified pyrimidine deoxynucleotides and oligonucleotide probes synthesized therewith
US5597909A (en) * 1994-08-25 1997-01-28 Chiron Corporation Polynucleotide reagents containing modified deoxyribose moieties, and associated methods of synthesis and use
US5681702A (en) * 1994-08-30 1997-10-28 Chiron Corporation Reduction of nonspecific hybridization by using novel base-pairing schemes
US5759776A (en) * 1995-06-05 1998-06-02 California Pacific Medical Center Targets for breast cancer diagnosis and treatment
US5776683A (en) * 1996-07-11 1998-07-07 California Pacific Medical Center Methods for identifying genes amplified in cancer cells
US5928870A (en) * 1997-06-16 1999-07-27 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6074825A (en) * 1997-07-31 2000-06-13 Maine Medical Center Stable encapsulated reference nucleic acid and method of making
US6004528A (en) * 1997-09-18 1999-12-21 Bergstein; Ivan Methods of cancer diagnosis and therapy targeted against the cancer stemline
US6153441A (en) * 1998-02-17 2000-11-28 Smithkline Beecham Corporation Methods of screening for agonists and antagonists for human CCR7 receptor and CKβ-9 ligand and interaction thereof
CA2365020C (en) * 1999-02-24 2010-10-19 Sumitomo Electric Industries, Ltd. Ganp proteins
GB0010191D0 (en) * 2000-04-26 2000-06-14 Cancer Res Campaign Tech Assays, methods and means
WO2003008583A2 (en) * 2001-03-02 2003-01-30 Sagres Discovery Novel compositions and methods for cancer

Similar Documents

Publication Publication Date Title
JP2006507794A5 (enExample)
JP2005514923A5 (enExample)
Bulyk Protein binding microarrays for the characterization of DNA–protein interactions
CA2488404A1 (en) Genes and polypeptides relating to human colon cancers
JP2005522999A5 (enExample)
JP2006518991A5 (enExample)
JP2007506426A5 (enExample)
JP2005512558A5 (enExample)
JP2003508022A5 (enExample)
CN105659085B (zh) 预测受试者对多激酶抑制剂的反应的基因表达标志及其使用方法
CA2362527A1 (en) A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer
Mahon et al. Is persistent adenovirus 12 infection involved in coeliac disease? A search for viral DNA using the polymerase chain reaction.
JP2008512984A5 (enExample)
CN110904231A (zh) 一种用于辅助诊断肝癌的试剂及其在制备试剂盒中的用途
JP2002518051A5 (enExample)
CA2428438A1 (en) Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
JP2004533825A5 (enExample)
WO2016042114A1 (en) Cxcl14 as a biomarker of hedgehog pathway activity for the diagnosis, prognosis and treatment of idiopathic pulmonary fibrosis
JP2005511023A5 (enExample)
JP2005535289A5 (enExample)
JP2005531290A5 (enExample)
CN107177676A (zh) 长链非编码rna nonhsat113026用于肾癌诊断分子标志物的用途
JP2004535795A5 (enExample)
JP2005526508A5 (enExample)
JP2006503575A5 (enExample)